Knowledge Centre
category guide

Orthopedic Implant Buying Guide: How to Evaluate Suppliers

November 20, 2026· 10 min read· Editor reviewed

Orthopedic implants are rarely bought like other medical supplies. The purchase usually covers a system: implants in many sizes, the instrument sets needed to place them, sterile processing, field support in the operating room, and a pricing contract that may run for several years. Surgeon preference carries a lot of weight, but so do regulatory status, traceability, and supply reliability.

This guide is for hospital value-analysis committees, ambulatory surgery center (ASC) administrators, and supply chain teams in the United States. It does not recommend a manufacturer. To compare suppliers, start with MedIndexer’s orthopedic implants category, which had 532 approved vendor listings as of November 2026. The category covers joint, trauma, spine, and extremity implant makers, along with orthobiologic, allograft, and contract-manufacturing suppliers.

Main types of orthopedic implants

FDA classifies orthopedic devices in 21 CFR Part 888. The classification regulation for each device type tells you whether it needs a 510(k) clearance (most Class II devices) or premarket approval (Class III). A few examples show the range:

Joint replacement

  • Knee: a common total knee design, with a metal femoral component and polyethylene tibial and patellar components fixed with bone cement, is Class II under 21 CFR 888.3560.
  • Hip: a hip system with a metal stem, a ceramic head, and a polyethylene cup is Class II under 21 CFR 888.3353. Metal-on-metal hip systems are Class III. FDA says no metal-on-metal total hip replacement devices are approved for marketing in the US, and that two metal-on-metal hip resurfacing devices are approved.
  • Bone cement: PMMA bone cement used to fix joint implants is Class II, with special controls, under 21 CFR 888.3027.

Trauma and fracture fixation

Plates, nail/plate and blade/plate combinations, and their screws are Class II under 21 CFR 888.3030. The regulation lists cobalt-chromium-molybdenum, stainless steel, and titanium as typical alloys. Bone screws, pins, and wires fall under 21 CFR 888.3040, and intramedullary rods for long-bone fractures under 21 CFR 888.3020. Both are also Class II.

Spine

Thoracolumbosacral pedicle screw systems are covered by 21 CFR 888.3070. They are Class II with special controls for the indications listed in that regulation. Intervertebral body fusion devices (interbody cages), which are made from materials including titanium and polymers, are Class II when they contain bone grafting material. They are Class III, and need premarket approval, if they include a therapeutic biologic such as a bone morphogenetic protein (21 CFR 888.3080).

Allograft and orthobiologics

Human bone and other tissue products are HCT/Ps under 21 CFR Part 1271. Some are regulated only under that part, and others as drugs, devices, or biologics. Ask the supplier which pathway applies to the specific product, because that determines which FDA registration and records you should expect.

What to verify before you buy

Regulatory status of the exact product

Clearance or approval applies to a specific device and its indications, not to a company. Ask for the 510(k) or PMA number for each implant system and look it up in FDA’s 510(k) and PMA databases. Check that the indications on the label match your intended procedures.

Confirm the manufacturer’s establishment registration and device listing in FDA’s public database. Registration alone proves little: under 21 CFR 807.39, registration or a registration number does not denote FDA approval of a firm or its products, and suggesting otherwise is misbranding.

Traceability and recalls

Under FDA’s UDI rule, device labelers must put a unique device identifier on labels and packages and submit device data to the Global Unique Device Identification Database (GUDID). Devices that are reused and reprocessed between uses, such as many surgical instruments, must also carry the UDI directly on the device. A UDI has a device identifier (labeler and model) and, when present on the label, production identifiers such as lot, serial number, and expiration date. You can look devices up in AccessGUDID. Ask how the supplier sends UDI and lot data to your systems, and how fast it notifies you of recalls, which FDA publishes in its medical device recall database.

MRI safety labeling

Patients with implants often need MRI later. FDA’s October 2023 guidance on testing and labeling devices for the MR environment recommends that labeling state a device’s MRI safety status as MR Safe, MR Unsafe, or MR Conditional, with the conditions for safe scanning when a device is MR Conditional. Ask for this labeling for every implant you put on contract.

Instruments, sets, and sterile processing

Each implant system comes with its own instruments. Before you sign, check how many sets the supplier will provide, whether they are loaned, consigned, or bought, how quickly replacements arrive, and whether your sterile processing department can validate the cleaning and sterilization instructions with its current equipment and turnaround times.

Why implant pricing deserves close attention

Public list prices for orthopedic implants are rarely published, so this guide does not state a current US price range. Published research does show how much implant price drives procedure cost:

  • In a study of 61 hospitals using 2008 data, average implant cost per case ranged from $1,797 to $12,093 for total knee replacement and from $2,392 to $12,651 for total hip replacement. Most of the variation came from differences between and within hospitals, not from patient characteristics (Robinson et al., JBJS, 2012).
  • In 8,647 primary hip and knee replacements at two hospitals (2015–2020), implant purchase price made up 49.5% of total inpatient costs and was the largest cost difference between high-cost and low-cost patients, at 4.4 times (Lizcano et al., JAAOS, 2023).
  • At one orthopedic specialty hospital, implant cost was 53.8% of total inpatient cost across 22,215 joint replacements (Carducci et al., JBJS, 2020).
  • Vizient says implants often account for 40–50% of procedural cost in ASCs.

These figures come from specific studies and settings. They are not current market prices. Ask each vendor for a written, itemized quote per construct or per case, and compare it with your GPO tier.

Payment changes that affect implant budgets

Site of service and bundled payment both put pressure on implant costs. CMS added total knee arthroplasty to the Medicare ASC covered procedures list for 2020, and total hip arthroplasty (CPT 27130) for 2021. CMS’s Transforming Episode Accountability Model (TEAM) is mandatory for selected hospitals and runs from January 1, 2026, to December 31, 2030. It covers 30-day episodes that include lower extremity joint replacement, surgical hip and femur fracture treatment, and spinal fusion. Participating hospitals receive target prices for those episodes, so implant spending counts against episode targets.

Questions to ask orthopedic implant suppliers

Send every vendor the same written request for information:

  • For each system: the 510(k) or PMA number, cleared or approved indications, and the current instructions for use.
  • Materials, size range, and which components are approved to be used together.
  • MRI safety status and conditions from the labeling.
  • How UDI and lot data are delivered, and how quickly recalls are communicated and replacement stock is supplied.
  • Inventory model (consignment, loaner sets, or purchase), instrument set count, and replenishment lead times.
  • Field support: rep coverage for scheduled and add-on cases, and credentialing paperwork.
  • Pricing per component and per construct, contract term, volume or market-share commitments, and price-protection terms.
  • For allograft or orthobiologics: the regulatory pathway and tissue-bank documentation.

Run a limited set of trial cases before you commit to full volume, and track tray completeness, delivery timing, support, and invoice accuracy.

Orthopedic implant suppliers listed on MedIndexer include Stryker, Globus Medical, Spinal Elements, Spineology, OrthoPediatrics, Onkos Surgical, The Orthopaedic Implant Company, Treace Medical Concepts, Vilex, and GLW. Treat them as a starting point for outreach, not a shortlist, and check each product’s FDA status yourself.

Red flags

  • A supplier calls a product “FDA registered” or “FDA approved” but cannot give a 510(k) or PMA number for that exact system.
  • No MRI safety information in the labeling.
  • Lot and UDI data available only on request, or no written recall-notification process.
  • A low implant price that leaves out instrument sets, loaner fees, or shipping.
  • A metal-on-metal total hip presented as currently FDA approved.

FAQ

Are orthopedic implants Class II or Class III devices?

Both, depending on the device type. Many plates, screws, intramedullary rods, and common hip and knee designs are Class II under 21 CFR Part 888. Metal-on-metal hip systems and interbody fusion devices that contain a therapeutic biologic are Class III and need premarket approval.

How can I confirm a specific implant is cleared or approved?

Get the 510(k) or PMA number from the supplier and look it up in FDA’s databases. Then check the device in AccessGUDID using the device identifier on its label.

Why do implant prices vary so much between hospitals?

Published studies point mainly to hospital-level factors and variation within hospitals, not to patient differences. Contract terms, purchasing volume, and how standardized surgeon preferences are all affect the price.

Can joint replacements be done in an ASC under Medicare?

Yes. CMS added total knee arthroplasty to the ASC covered procedures list for 2020 and total hip arthroplasty for 2021. Whether a particular patient is suitable for an ASC is a clinical decision.

Where can I compare orthopedic implant suppliers?

Browse the orthopedic implants category or the full directory. Browsing and contacting vendors is free. Manufacturers and distributors that are not listed yet can add or claim a profile on the for suppliers page.

Sources

Disclaimer: This article is general procurement information, not clinical, legal, or reimbursement advice. Regulatory references and published cost data were checked on 20 November 2026 and can change. Confirm current device status, labeling, and pricing with the vendor and with official FDA and CMS records. MedIndexer publishes neutral guidance and does not accept payment from vendors to influence the content of articles.

Browse vendors in

MedIndexer publishes neutral guidance. We do not accept payment from vendors to influence the content of articles.

This article was prepared with AI assistance and may contain errors or out-of-date figures. Check the cited sources and confirm details with vendors before making procurement decisions.

Reviewed by the MedIndexer editorial team ·

For general procurement information only. Not medical, clinical, regulatory or legal advice.

Suggest a correction

See something wrong, missing, or out-of-date? Tell us what should change. Our AI reviews each comment against the article and flags credible corrections to the editor team — if your input is right, the article gets updated.

0 / 4000 characters. Be specific — point at the line or claim, and say what should be there instead.

Weekly industry newsletter

Weekly industry briefing

Double opt-in. One email a week, one-click unsubscribe, no sharing of your address.